The European stock market has been buzzing with the rise of a select group of heavyweights, affectionately called the GRANOLAS. Coined by Goldman Sachs, this nickname refers to eleven European companies that have eclipsed the broader stock market’s performance in recent years. In this blog post, we will delve into who the GRANOLAS are and why they have become Europe’s magnificent stocks.
Tag Archives: Novo Nordisk
The European stock market in 2023: who are the big winners?
Despite early-year doubts, Europe’s stock market has defied expectations with a remarkable rebound in 2023. The Euro Stoxx 50, a key benchmark for European corporate giants, has surged by an impressive 19%, rebounding from a 12% drop in 2022.
This resurgence has been driven by a combination of factors, including easing economic concerns, improving corporate earnings, and a shift in investor sentiment.
And, against the background of the overall good performance, there are companies that stood out, posting impressive growth.
The Quest For the Wonder Slimming Pill
Obesity is becoming an increasingly serious problem and is officially considered the number 1 cause of death. According to World Health Organisation estimates, in one decade the numbers have tripled. Now more than 1 billion people worldwide are obese – 650 million adults, 340 million adolescents and 39 million children. This number is still rising and by 2025, another approximately 167 million people – adults and children – will become less healthy because they are overweight or obese.